Kenner C Rice Selected Research

Kenner C Rice Research Topics

Disease

41	Pain (Aches) 04/2024 - 01/2003
26	Hyperalgesia 04/2022 - 03/2006
20	Substance-Related Disorders (Drug Abuse) 03/2024 - 01/2004
11	Alcoholism (Alcohol Abuse) 01/2023 - 12/2007
11	Opioid-Related Disorders (Opiate Addiction) 02/2022 - 01/2003
11	Neuralgia (Stump Neuralgia) 01/2022 - 11/2007
11	Inflammation (Inflammations) 01/2021 - 06/2002
7	Obesity 01/2018 - 01/2004
7	Cocaine-Related Disorders (Cocaine Addiction) 03/2016 - 03/2002
6	Memory Disorders (Memory Loss) 03/2024 - 01/2018
6	Hyperthermia 01/2022 - 05/2004
6	Chronic Pain 05/2021 - 03/2006
6	Body Weight (Weight, Body) 01/2018 - 08/2012
6	Hypersensitivity (Allergy) 01/2018 - 03/2006
5	Respiratory Insufficiency (Respiratory Failure) 04/2024 - 11/2009
4	Neuroinflammatory Diseases 04/2022 - 01/2019
4	Infections 11/2019 - 01/2003
4	Seizures (Absence Seizure) 01/2019 - 02/2006
4	Neoplasms (Cancer) 01/2018 - 11/2005
4	Acute Pain 02/2015 - 07/2005
3	Premature Birth (Birth, Premature) 04/2020 - 11/2016
3	Weight Loss (Weight Reduction) 01/2019 - 06/2002
3	Schizophrenia (Dementia Praecox) 01/2018 - 09/2002
3	Bulimia (Binge Eating) 10/2017 - 09/2012
3	Feeding and Eating Disorders (Eating Disorder) 10/2017 - 01/2004
2	Tetanus 12/2023 - 06/2021
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2022 - 01/2021
2	Peripheral Nerve Injuries 01/2022 - 01/2018
2	Fetal Death 01/2020 - 11/2016
2	Perinatal Death 01/2020 - 11/2016
2	Autistic Disorder (Autism) 01/2019 - 09/2009

Drug/Important Bio-Agent (IBA)

34	Opioid Analgesics (Opioids)IBA 04/2024 - 09/2002
18	Morphine (MS Contin)FDA LinkGeneric 09/2022 - 01/2003
15	Analgesics (Analgesic Drugs)IBA 04/2024 - 11/2005
13	Toll-Like Receptor 4IBA 01/2021 - 07/2008
11	Naltrexone (ReVia)FDA LinkGeneric 01/2021 - 07/2008
10	Dopamine (Intropin)FDA LinkGeneric 01/2023 - 05/2006
10	Opioid Receptors (Opioid Receptor)IBA 04/2022 - 03/2006
10	Serotonin (5 Hydroxytryptamine)IBA 01/2018 - 09/2009
8	Ethanol (Ethyl Alcohol)IBA 01/2021 - 01/2009
8	4- (alpha- (4- allyl- 2,5- dimethyl- 1- piperazinyl)- 3- methoxybenzyl)- N,N- diethylbenzamideIBA 01/2020 - 11/2005
7	Synthetic CathinoneIBA 03/2024 - 11/2014
7	VaccinesIBA 02/2022 - 09/2014
7	Naloxone (Narcan)FDA LinkGeneric 04/2020 - 07/2008
6	Fentanyl (Sublimaze)FDA LinkGeneric 04/2024 - 04/2014
6	Cocaine (Cocaine HCl)IBA 03/2024 - 10/2006
6	Heroin (Diamorphine)IBA 12/2023 - 01/2017
6	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 01/2019 - 04/2005
6	Interleukin-6 (Interleukin 6)IBA 01/2018 - 08/2007
5	LigandsIBA 10/2021 - 03/2002
5	R 121919IBA 01/2018 - 04/2009
5	Corticotropin-Releasing HormoneIBA 01/2016 - 06/2002
4	AcidsIBA 04/2024 - 10/2010
4	Minocycline (Cyclops)FDA LinkGeneric 04/2022 - 10/2014
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2016
4	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021 - 11/2007
4	Methadone (Dolophine)FDA LinkGeneric 11/2020 - 01/2012
4	Narcotic Antagonists (Opioid Antagonists)IBA 04/2020 - 07/2008
4	volinanserinIBA 01/2019 - 05/2004
4	antalarminIBA 01/2018 - 06/2002
4	Nalbuphine (Nubain)FDA LinkGeneric 01/2018 - 11/2010
4	Capsaicin (Zostrix)FDA Link 01/2018 - 09/2008
4	CRF receptor type 1IBA 10/2017 - 12/2007
3	AntibodiesIBA 12/2023 - 09/2014
3	InflammasomesIBA 04/2022 - 01/2016
3	HaptensIBA 02/2022 - 02/2016
3	Interleukin-17 (Interleukin 17)IBA 01/2022 - 01/2021
3	Dynorphins (Dynorphin)IBA 05/2021 - 03/2006
3	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2020 - 01/2017
3	CytokinesIBA 11/2019 - 08/2007
3	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 01/2019 - 05/2004
3	NeuropeptidesIBA 01/2018 - 11/2012
3	lorcaserinIBA 01/2018 - 12/2015
3	CorticosteroneIBA 01/2018 - 06/2002
3	Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA 10/2017 - 01/2004
3	RimonabantIBA 10/2014 - 11/2013
3	CannabinoidsIBA 09/2014 - 11/2013
3	GABA-B ReceptorsIBA 03/2013 - 10/2010
3	delta Opioid Receptors (delta Opioid Receptor)IBA 04/2012 - 11/2005
3	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2007 - 03/2002
2	mu Opioid Receptors (mu Opioid Receptor)IBA 04/2024 - 01/2018
2	Caffeine (No Doz)FDA LinkGeneric 03/2024 - 01/2024
2	Ghrelin ReceptorsIBA 01/2023 - 11/2021
2	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 04/2022 - 01/2022
2	NLR ProteinsIBA 01/2022 - 01/2016
2	Myelin-Oligodendrocyte GlycoproteinIBA 01/2022 - 01/2021
2	norbinaltorphimineIBA 05/2021 - 06/2010
2	Sigma-1 ReceptorIBA 01/2021 - 01/2015
2	1- (2- (3,4- dichlorophenyl)ethyl)- 4- methylpiperazineIBA 01/2021 - 01/2015
2	Messenger RNA (mRNA)IBA 01/2021 - 02/2006
2	Toll-Like Receptor 2IBA 01/2021 - 05/2012
2	Platelet Activating FactorIBA 04/2020 - 01/2020
2	Amphetamine (Amfetamine)FDA LinkGeneric 01/2019 - 04/2005
2	Oxycodone (Oxycontin)FDA LinkGeneric 01/2018 - 02/2016
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2018 - 08/2013
2	SaltsIBA 01/2018 - 04/2015

Therapy/Procedure

8	Therapeutics 01/2023 - 01/2007
6	Analgesia 04/2022 - 11/2007
5	Self Administration (Administration, Self) 03/2024 - 12/2007
2	Spinal Injections 01/2022 - 05/2013